|
VEPH1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.68476343986868E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.75515157962991E-12 |
| Normal-vs-Stage2 |
1.32370000516246E-08 |
| Normal-vs-Stage3 |
2.48410000347477E-08 |
| Normal-vs-Stage4 |
3.30000005099862E-09 |
| Stage1-vs-Stage2 |
6.410800E-01 |
| Stage1-vs-Stage3 |
9.373200E-01 |
| Stage1-vs-Stage4 |
7.122100E-02 |
| Stage2-vs-Stage3 |
6.872200E-01 |
| Stage2-vs-Stage4 |
3.282800E-01 |
| Stage3-vs-Stage4 |
2.164400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.11419770579369E-12 |
| Normal-vs-AfricanAmerican |
1.64560000071035E-08 |
| Normal-vs-Asian |
1.091760E-02 |
| Caucasian-vs-AfricanAmerican |
9.441000E-01 |
| Caucasian-vs-Asian |
6.122800E-01 |
| AfricanAmerican-vs-Asian |
6.424000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.65839997290362E-09 |
| Normal-vs-Female |
7.54490000000052E-05 |
| Male-vs-Female |
7.478500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.08989986111897E-10 |
| Normal-vs-Extreme_Weight |
1.16770004776612E-09 |
| Normal-vs-Obese |
1.76930999999936E-05 |
| Normal-vs-Extreme_Obese |
7.1112999999734E-07 |
| Normal_Weight-vs-Extreme_Weight |
8.323000E-01 |
| Normal_Weight-vs-Obese |
2.103800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.805800E-01 |
| Extreme_Weight-vs-Obese |
1.001600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.040000E-01 |
| Obese-vs-Extreme_Obese |
3.497600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.75059999829585E-08 |
| Normal-vs-Age(41-60Yrs) |
1.83339999848542E-08 |
| Normal-vs-Age(61-80Yrs) |
5.55111512312578E-15 |
| Normal-vs-Age(81-100Yrs) |
6.15609999999878E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.053640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.954400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.833000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.946420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.749000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.657600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.40139028054409E-12 |
| Normal-VS-Type2 PRCC |
5.3629000129618E-09 |
| Normal-VS-KIRP CIMP |
6.55853149567065E-12 |
| Normal-VS-Unclassified PRCC |
3.77310000000408E-05 |
| Type1 PRCC-VS-Type2 PRCC |
5.583600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.412100E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.023450E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.182980E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.902200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.55610000000573E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.87649995542216E-09 |
| Normal-vs-N1 |
3.81860000000511E-05 |
| Normal-vs-N2 |
1.53550505643807E-11 |
| N0-vs-N1 |
3.507600E-01 |
| N0-vs-N2 |
1.295300E-03 |
| N1-vs-N2 |
1.659710E-02 |
|
|
